JP2022520232A5 - - Google Patents

Info

Publication number
JP2022520232A5
JP2022520232A5 JP2021546891A JP2021546891A JP2022520232A5 JP 2022520232 A5 JP2022520232 A5 JP 2022520232A5 JP 2021546891 A JP2021546891 A JP 2021546891A JP 2021546891 A JP2021546891 A JP 2021546891A JP 2022520232 A5 JP2022520232 A5 JP 2022520232A5
Authority
JP
Japan
Prior art keywords
gene therapy
therapy vector
raav gene
raav
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021546891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022520232A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/017987 external-priority patent/WO2020167996A1/en
Publication of JP2022520232A publication Critical patent/JP2022520232A/ja
Publication of JP2022520232A5 publication Critical patent/JP2022520232A5/ja
Priority to JP2025007633A priority Critical patent/JP2025063228A/ja
Pending legal-status Critical Current

Links

JP2021546891A 2019-02-12 2020-02-12 ダノン病の治療のための遺伝子療法ベクター Pending JP2022520232A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025007633A JP2025063228A (ja) 2019-02-12 2025-01-20 ダノン病の治療のための遺伝子療法ベクター

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962804521P 2019-02-12 2019-02-12
US62/804,521 2019-02-12
US201962934928P 2019-11-13 2019-11-13
US62/934,928 2019-11-13
PCT/US2020/017987 WO2020167996A1 (en) 2019-02-12 2020-02-12 Gene therapy vectors for treatment of danon disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025007633A Division JP2025063228A (ja) 2019-02-12 2025-01-20 ダノン病の治療のための遺伝子療法ベクター

Publications (2)

Publication Number Publication Date
JP2022520232A JP2022520232A (ja) 2022-03-29
JP2022520232A5 true JP2022520232A5 (enExample) 2023-02-21

Family

ID=72043957

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021546891A Pending JP2022520232A (ja) 2019-02-12 2020-02-12 ダノン病の治療のための遺伝子療法ベクター
JP2025007633A Pending JP2025063228A (ja) 2019-02-12 2025-01-20 ダノン病の治療のための遺伝子療法ベクター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025007633A Pending JP2025063228A (ja) 2019-02-12 2025-01-20 ダノン病の治療のための遺伝子療法ベクター

Country Status (12)

Country Link
US (1) US20220143215A1 (enExample)
EP (1) EP3924371A4 (enExample)
JP (2) JP2022520232A (enExample)
KR (1) KR20210125999A (enExample)
CN (2) CN120324641A (enExample)
AU (3) AU2020221842A1 (enExample)
BR (1) BR112021015751A2 (enExample)
CA (1) CA3128514A1 (enExample)
IL (1) IL285238A (enExample)
MX (1) MX2021009696A (enExample)
SG (1) SG11202107744SA (enExample)
WO (1) WO2020167996A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE055862T2 (hu) 2016-04-20 2021-12-28 Centro De Investig Energeticas Készítmények és eljárások PKLR fokozott génexpressziójára
SG11202002263TA (en) 2017-10-16 2020-04-29 Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency
WO2019200167A1 (en) 2018-04-11 2019-10-17 Rocket Pharmaceuticals, Ltd. Compositions and methods for stem cell transplant
MX2020011386A (es) 2018-04-27 2021-01-29 Spacecraft Seven Llc Terapia genica para la degeneracion del snc.
KR102918544B1 (ko) * 2018-07-12 2026-01-27 로켓 파마슈티컬스, 리미티드 다논병을 치료하기 위한 유전자 요법 벡터
KR20230043869A (ko) 2020-08-07 2023-03-31 스페이스크래프트 세븐, 엘엘씨 Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법
CN116887868A (zh) * 2020-12-07 2023-10-13 太空飞船七有限责任公司 达农病的治疗
CN114874990A (zh) * 2021-02-05 2022-08-09 中国科学院苏州纳米技术与纳米仿生研究所 一种功能化外泌体及其制备方法和应用
US12609410B2 (en) 2021-09-23 2026-04-21 Lg Energy Solution, Ltd. High heat-resistant connector, and battery module, battery pack, and vehicle including the same
CN114457112A (zh) * 2022-02-07 2022-05-10 苏州市立医院 一种特异性神经靶向mr分子探针及其制备方法和应用
CN115975051B (zh) * 2022-11-17 2025-09-12 东南大学 靶向外泌体及制备方法、应用、药物和药物递送系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002350039A1 (en) * 2001-10-29 2003-05-12 Renovis, Inc. Method for isolating cell-type specific mrnas
US9217155B2 (en) * 2008-05-28 2015-12-22 University Of Massachusetts Isolation of novel AAV'S and uses thereof
US9434928B2 (en) * 2011-11-23 2016-09-06 Nationwide Children's Hospital, Inc. Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
MX367100B (es) * 2012-02-17 2019-08-05 The Children´S Hospital Of Philadelphia Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos.
PT3405215T (pt) * 2016-01-19 2022-09-20 Univ California Métodos para o tratamento da doença de danon e outros transtornos da autofagia
CA3011939A1 (en) * 2016-02-02 2017-08-10 University Of Massachusetts Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
WO2019028273A1 (en) * 2017-08-02 2019-02-07 Dna2.0, Inc. Dba Atum DNA VECTORS AND ELEMENTS FOR SUSTAINED GENE EXPRESSION IN EUKARYOTIC CELLS
KR102918544B1 (ko) * 2018-07-12 2026-01-27 로켓 파마슈티컬스, 리미티드 다논병을 치료하기 위한 유전자 요법 벡터
EP3833745A1 (en) * 2018-08-10 2021-06-16 REGENXBIO Inc. Scalable method for recombinant aav production

Similar Documents

Publication Publication Date Title
JP2022520232A5 (enExample)
JP2021531752A5 (enExample)
AU2023201237B2 (en) Gene therapy vectors for treatment of Danon Disease
CN111902539B (zh) 杂合调控元件
JP2026050416A (ja) ダノン病およびオートファジーの他の障害の治療のための方法
JP2024523707A5 (enExample)
JP7654562B2 (ja) 線維芽細胞増殖因子23関連低リン血症性疾患の遺伝子療法
US20240002462A1 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs
KR20240118855A (ko) 바이러스 벡터로 bag-3 관련 심근병증을 치료하는 방법 및 조성물
JP2021520811A (ja) ヘキソサミニダーゼアルファおよびベータサブユニットをコードしているバイシストロニックaavベクターならびにその使用
JP2024545186A (ja) ウイルスベクターによるmybpc3関連肥大型心筋症を処置するための方法および組成物
JP2024509792A (ja) ファブリー病の治療のための組成物及び方法
JP7301860B2 (ja) コア-シェル構造のマイクロ粒子を有効成分として含む成長因子遺伝子発現増加用組成物
KR20230029624A (ko) 유전자 치료를 위한 글루코스-6-포스파타제(G6Pase-a)를 코딩하는 벡터
JP2022530359A5 (enExample)
JP2022530264A5 (enExample)
RU2024118293A (ru) Векторы для генной терапии для лечения болезни данона
RU2822925C2 (ru) Векторы для генной терапии для лечения болезни данона
JP2022514271A5 (enExample)
RU2021121516A (ru) Векторы для генной терапии для лечения болезни данона
RU2023129510A (ru) Геннотерапевтические векторы для лечения болезни данона
US11390854B2 (en) Human porphobilinogen deaminase derived proteins and polynucleotides and uses thereof
WO2025096910A1 (en) Cpg-free codon-optimized human microdystrophin for duchenne muscular dystrophy gene therapy
WO2025253097A1 (en) Proteins with cardiopreservation activity
CN116376921A (zh) 一种用于治疗糖尿病的aav载体及其用途